GlaxoSmithKline PLC (GSK) — Financial Flexibility Index
GlaxoSmithKline PLC (GSK) has a Financial Flexibility Index of 0.07x as of September 2025. Free cash flow of GBX3.10 Billion (operating CF GBX2.22 Billion minus capex GBX879.00 Million) represents 0% of total liabilities (GBX45.59 Billion). Check how aggressively does GlaxoSmithKline PLC reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
GlaxoSmithKline PLC Financial Flexibility Index (1991–2024)
Historical Financial Flexibility Index trend for GlaxoSmithKline PLC across 35 annual periods. For the full cash flow conversion analysis, see GSK operating cash flow.
Annual Financial Flexibility Index for GlaxoSmithKline PLC (1991–2024)
Year-by-year free cash flow to debt coverage for GlaxoSmithKline PLC. Explore GlaxoSmithKline PLC cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (GBX) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.21x | GBX9.54 Billion | GBX6.55 Billion | GBX46.38 Billion | ▲ +4.3% |
| 2023 | 0.20x | GBX9.11 Billion | GBX6.77 Billion | GBX46.21 Billion | ▲ +2.2% |
| 2022 | 0.19x | GBX9.66 Billion | GBX7.40 Billion | GBX50.05 Billion | ▲ +2.4% |
| 2021 | 0.19x | GBX10.88 Billion | GBX7.95 Billion | GBX57.76 Billion | ▲ +5.2% |
| 2020 | 0.18x | GBX10.68 Billion | GBX8.44 Billion | GBX59.62 Billion | ▲ +7.9% |
| 2019 | 0.17x | GBX10.18 Billion | GBX8.02 Billion | GBX61.34 Billion | ▼ -11.6% |
| 2018 | 0.19x | GBX10.22 Billion | GBX8.42 Billion | GBX54.39 Billion | ▲ +8.9% |
| 2017 | 0.17x | GBX9.12 Billion | GBX6.92 Billion | GBX52.89 Billion | ▲ +5.5% |
| 2016 | 0.16x | GBX8.85 Billion | GBX6.50 Billion | GBX54.12 Billion | ▲ +63.0% |
| 2015 | 0.10x | GBX4.47 Billion | GBX2.57 Billion | GBX44.57 Billion | ▼ -48.3% |
| 2014 | 0.19x | GBX6.93 Billion | GBX5.18 Billion | GBX35.72 Billion | ▼ -25.5% |
| 2013 | 0.26x | GBX8.92 Billion | GBX7.22 Billion | GBX34.27 Billion | ▲ +53.4% |
| 2012 | 0.17x | GBX5.89 Billion | GBX4.38 Billion | GBX34.73 Billion | ▼ -27.8% |
| 2011 | 0.23x | GBX7.58 Billion | GBX6.25 Billion | GBX32.25 Billion | ▼ -10.0% |
| 2010 | 0.26x | GBX8.43 Billion | GBX6.80 Billion | GBX32.31 Billion | ▼ -13.7% |
| 2009 | 0.30x | GBX9.71 Billion | GBX7.84 Billion | GBX32.12 Billion | ▲ +0.2% |
| 2008 | 0.30x | GBX9.38 Billion | GBX7.31 Billion | GBX31.07 Billion | ▼ -19.8% |
| 2007 | 0.38x | GBX7.94 Billion | GBX5.79 Billion | GBX21.09 Billion | ▲ +7.9% |
| 2006 | 0.35x | GBX5.55 Billion | GBX3.96 Billion | GBX15.90 Billion | ▲ +1.2% |
| 2005 | 0.34x | GBX6.77 Billion | GBX5.59 Billion | GBX19.63 Billion | ▲ +16.8% |
| 2004 | 0.30x | GBX5.02 Billion | GBX4.77 Billion | GBX17.01 Billion | ▼ -23.1% |
| 2003 | 0.38x | GBX5.91 Billion | GBX4.85 Billion | GBX15.40 Billion | ▲ +33.9% |
| 2002 | 0.29x | GBX4.29 Billion | GBX3.06 Billion | GBX14.94 Billion | ▼ -32.0% |
| 2001 | 0.42x | GBX5.73 Billion | GBX4.61 Billion | GBX13.57 Billion | ▲ +80.5% |
| 2000 | 0.23x | GBX2.96 Billion | GBX1.85 Billion | GBX12.63 Billion | ▲ +52.8% |
| 1999 | 0.15x | GBX1.11 Billion | GBX510.00 Million | GBX7.23 Billion | ▲ +13.7% |
| 1998 | 0.13x | GBX885.00 Million | GBX410.00 Million | GBX6.58 Billion | ▼ -14.5% |
| 1997 | 0.16x | GBX1.03 Billion | GBX615.00 Million | GBX6.55 Billion | ▼ -11.3% |
| 1996 | 0.18x | GBX1.25 Billion | GBX849.00 Million | GBX7.05 Billion | ▼ -23.8% |
| 1995 | 0.23x | GBX1.94 Billion | GBX1.25 Billion | GBX8.32 Billion | ▼ -40.3% |
| 1995 | 0.39x | GBX2.93 Billion | GBX2.45 Billion | GBX7.53 Billion | ▼ -34.4% |
| 1994 | 0.59x | GBX1.63 Billion | GBX1.05 Billion | GBX2.74 Billion | ▲ +8.5% |
| 1993 | 0.55x | GBX1.53 Billion | GBX927.00 Million | GBX2.80 Billion | ▼ -10.5% |
| 1992 | 0.61x | GBX1.25 Billion | GBX657.00 Million | GBX2.04 Billion | ▲ +23.5% |
| 1991 | 0.50x | GBX1.22 Billion | GBX615.00 Million | GBX2.46 Billion | — |